Weijia Dou
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Genomics, phytochemicals, and oxidative stress 2
- Co-authors
- Shoujie Zhao (5 shared papers)Lei Liu (5 shared papers)Fengrong Hu (1 shared paper)Lijie He (1 shared paper)Shuli Liang (1 shared paper)Daiming Fan (2 shared papers)Yongzhan Nie (2 shared papers)Kaichun Wu (1 shared paper)
- Journals
- Annals of Translational Medicine (4 papers)BMC Psychiatry (1 paper)PLoS ONE (1 paper)Neurogastroenterology & Motility (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weijia Dou
12 papers receiving 429 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 140
- Hepatology 47
- Molecular Biology 238
- Molecular Medicine 17
- Immunology 44
Countries citing papers authored by Weijia Dou
This map shows the geographic impact of Weijia Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijia Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijia Dou more than expected).
Fields of papers citing papers by Weijia Dou
This network shows the impact of papers produced by Weijia Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijia Dou. The network helps show where Weijia Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Weijia Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 155 | |
| 2 | 2021 | 87 | |
| 3 | 2015 | 55 | |
| 4 | 2016 | 51 | |
| 5 | 2020 | 31 | |
| 6 | 2020 | 19 | |
| 7 | 2023 | 15 | |
| 8 | 2019 | 6 | |
| 9 | 2020 | 6 | |
| 10 | 2020 | 4 | |
| 11 | 2025 | 2 | |
| 12 | 2012 | 2 | |
| 13 | 2019 | 1 | |
| 14 | 2025 | 0 |
About Weijia Dou
Weijia Dou is a scholar working on Hepatology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 14 papers that have together received 434 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Macrophage Migration Inhibitory Factor (1 paper), Cancer-related molecular mechanisms research (1 paper), Ferroptosis and cancer prognosis (1 paper), MicroRNA in disease regulation (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (140 citations), Hepatology (47 citations), Molecular Biology (238 citations), Molecular Medicine (17 citations) and Immunology (44 citations). Weijia Dou has collaborated with scholars based in China and United States. Frequent co-authors include Shoujie Zhao, Lei Liu, Fengrong Hu, Lijie He, Shuli Liang, Daiming Fan, Yongzhan Nie, Kaichun Wu, Yong Gu and Changcun Guo. Their work appears in journals such as Annals of Translational Medicine, BMC Psychiatry, PLoS ONE, Neurogastroenterology & Motility and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.